A new frontier in cancer therapy: harnessing the power of our own microbes.
For decades, scientists have viewed cancer and bacteria as two very different biological worlds — one representing a deadly disease, the other a microscopic organism that could either harm or help us. But now, a groundbreaking discovery from the Medical Research Council (MRC) Laboratory of Medical Sciences, Imperial College London, and the University of Cologne is blurring that boundary in the most unexpected way.
Researchers have found that bacteria living inside tumourscan actually help fight cancer — by producing a molecule that makes chemotherapy far more effective.
The Hidden Allies Inside Tumours
It’s well known that our bodies are teeming with microbes — from our skin to our gut — forming what’s known as the microbiome. But what scientists are now uncovering is that tumours themselves host tiny microbial communities, and these bacterial guests might not always be enemies.
In this new study, published in Cell Systems (September 2025), researchers discovered that certain tumour-associatedbacteria produce a compound called 2-methylisocitrate (2-MiCit). This molecule has shown an astonishing ability to weaken cancer cells and enhance the effects of chemotherapy, particularly in colorectal cancer.
The Molecule that Makes Chemotherapy Stronger
Through a large-scale screening of over 1,100 conditions using the model organism C. elegans (a tiny worm often used in biological studies), scientists identified a strain of E. coli that produced 2-MiCit. When combined with the chemotherapy drug 5-fluorouracil (5-FU), the molecule boosted the drug’s ability to kill cancer cells by disrupting their metabolism and damaging their DNA.
Further experiments in human cancer cells and fruit flies confirmed its potential — the molecule not only slowed down tumor growth but also extended survival in fly models of colorectal cancer.
How It Works: A Multi-Pronged Attack
The power of 2-MiCit lies in its ability to target the mitochondria — the energy factories within our cells. By inhibiting a crucial mitochondrial enzyme, it causes the cancer cells to experience energy stress and DNA damage.
This dual attack — metabolic disruption plus DNA damage — leaves cancer cells far more vulnerable to chemotherapy. As a result, when used alongside 5-FU, the combined effect is significantly more potent than either treatment on its own.. One of these bacterial chemicals acts as a powerful partner for chemotherapy, disrupting the metabolism of cancer cells and making them more vulnerable to the drug.”
Rethinking the Role of Microbes in Cancer
This discovery shifts how scientists perceive the tumourmicroenvironment — the ecosystem of cells, molecules, and microbes surrounding a cancerous growth.
It’s a holistic view of cancer biology, one that recognisesmicrobes as active participants rather than passive bystanders.
What This Means for the Future of Cancer Treatment
The implications of this research are enormous. Scientists could one day develop new drugs inspired by 2-MiCit, or even use engineered bacteria to produce therapeutic molecules directly inside tumours.
This “microbe-assisted medicine” could revolutionise cancer therapy — transforming our understanding of how the body, its cells, and its microbial companions interact in health and disease.
Imagine a future where the bacteria hiding within tumour aren’t just tolerated, but enlisted as allies in the fight against cancer.
In Summary
Final Thought
In the ongoing war against cancer, help may be coming from an unexpected ally — the bacteria living within the enemy itself.
Our own microbes, once thought to simply coexist with disease, might turn out to be the key to conquering
source – https://www.sciencedaily.com/releases/2025/10/251007081835.htm